Gene747
DAGLA: diacylglycerol lipase alpha
Cite this record
ConductScience Library. DAGLA: diacylglycerol lipase alpha. Genes, record 747. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/747
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y4D2 | Diacylglycerol lipase-alpha | 1,042 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents69
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260337666 A1 | 2026-10-29 | 27075 | Q9Y4D2 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 1230 | Q9Y4D2 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 1211 | Q9Y4D2 | Espacenet |
| US 12577609 B2 | 2026-03-17 | 27075 | Q9Y4D2 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43718 | Q9Y4D2 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1230 | Q9Y4D2 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1211 | Q9Y4D2 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1211 | Q9Y4D2 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1211 | Q9Y4D2 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1230 | Q9Y4D2 | Espacenet |
NIH grants547
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DAGLA papers | Newest fiscal year |
|---|---|---|---|
| P30DK063491 | Diabetes Research Center (DRC) | 5 | 2025 |
| T32MH065215 | Postdoctoral Program in Functional Neurogenomics | 5 | 2025 |
| R01DA043571 | Endocannabinoid Biosynthesis in Inflammation and Pain | 4 | 2025 |
| R01MH107435 | 2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation | 4 | 2025 |
| R01MH107182 | Postsynaptic roles of ankyrins | 3 | 2025 |
| ZIAAA000375 | Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury | 3 | 2025 |
| ZIAAA000416 | Corticostriatal mechanisms of action learning and habit formation | 3 | 2025 |
| P30CA012197 | Cancer Center Support Grant | 2 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 2 | 2025 |
| P50HD103537 | Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt | 2 | 2025 |
Source NIH's project files
Papers500
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tai Chi exercise of short duration alters circulating oxylipins in postmenopausal women: a pilot study. | Front Med (Lausanne) | 2026 | 42740961 | PubTator, text mining | PubMed |
| Exploring sex differences in endocannabinoid system biomarkers and their relationship with antidepressant treatment outcomes in major depressive disorder: a CAN-BIND 1 secondary analysis. | Eur Arch Psychiatry Clin Neurosci | 2026 | 42640306 | PubTator, text mining | PubMed |
| Systematic Integration of genomics with transcriptomics for the Study of Coronary Artery Disease and Subclinical Atherosclerosis. | medRxiv | 2026 | 42620441 | PubTator, text mining | PubMed |
| Integrative network analysis reveals organizational principles of the endocannabinoid system. | J Cannabis Res | 2026 | 42129940 | PubTator, text mining | PubMed |
| Anti-CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked? | Ann Clin Transl Neurol | 2026 | 42028700 | PubTator, text mining | PubMed |
| Proceedings of the 3rd edition of the International e-Health Forum 2024. | BMC Proc | 2026 | 41906146 | PubTator, text mining | PubMed |
| Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A Case Report. | Front Immunol | 2026 | 41782875 | PubTator, text mining | PubMed |
| Exploring the Endocannabinoid System's Influence on Mammary Tissue and Breast Milk Inflammation in Maternal Chronic Obesity. | Biomolecules | 2026 | 41750272 | PubTator, text mining | PubMed |
| Altered endocannabinoid system gene expression in inflammatory bowel disease mucosa: New perspectives in inflammatory bowel disease management. | World J Gastrointest Endosc | 2026 | 41700170 | PubTator, text mining | PubMed |
| Response to Critical Appraisal of a Reported Case of DAGLA Associated Cerebellitis. | Cerebellum | 2025 | 41273603 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/747
GET https://conductscience.org/api/genes/v1/747/patents?page=2